Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2Phase 3 Interventional

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

ClinicalTrials.gov ID: NCT07363694

Public ClinicalTrials.gov record NCT07363694. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 10, 2026, 9:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AN INTERVENTIONAL PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, THIRD PARTY-UNBLINDED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE EFFICACY AND SAFETY OF PF-07275315 IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical trial is to learn about the effects and safety of the study medicine PF-07275315 for the potential treatment of COPD. COPD is a condition that makes it difficult to breathe, which negatively impacts the quality of life and functioning of people who are affected. This study is seeking participants who: * Are 35 to 80 years old * Have had moderate-to-severe COPD for at least 12 months * Have a documented history of at least 2 moderate or severe exacerbations within the last 12 months * Have been continuously taking their regular maintenance treatment(s) for COPD over at least 6 months at a stable dose for 3 months All participants will receive PF-07275315 or a placebo. A placebo does not have any medicine in it but looks just like the medicine being studied. PF-07275315 or placebo will be given as multiple shots in the clinic over the course of 24 weeks for the Phase 2 part and 52 weeks for the Phase 3 part. We will compare the results of people receiving PF-07275315 to those of the people who do not. This will help us determine if PF-07275315 is safe and effective. Participants who will be involved in the Phase 2 part of the study for about 40 weeks. During this time, they will have 11 visits at the study clinic. Participants who will be involved in the Phase 3 part of the study for about 68 weeks. During this time, they will have 18 visits at the study clinic.

Study identification

NCT ID
NCT07363694
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
1,156 participants

Conditions and interventions

Eligibility (public fields only)

Age range
35 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 10, 2026
Primary completion
Oct 23, 2030
Completion
Jan 15, 2031
Last update posted
Aug 30, 2026

2026 – 2031

United States locations

U.S. sites
61
U.S. states
21
U.S. cities
51
Facility City State ZIP Site status
University of Alabama at Birmingham Lung Health Center Birmingham Alabama 35233 Recruiting
SEC Clinical Research Dothan Alabama 36305 Recruiting
Pulmonary Associates of Mobile, P.C. Mobile Alabama 36608 Recruiting
Chandler Clinical Trials Chandler Arizona 85224 Not yet recruiting
Pulmonary Associates, PA Phoenix Arizona 85027 Recruiting
IMAX Clinical Trials La Palma California 90623 Recruiting
NewportNativeMD, Inc. Newport Beach California 92663 Recruiting
California Medical Research Associates Northridge California 91324 Recruiting
Institute of HealthCare Assessment d/b/a Apex Clinical Research San Diego California 92120 Recruiting
Finlay Medical Research Greenacres City Florida 33467 Recruiting
Clinical Research Specialists LLC Kissimmee Florida 34746 Recruiting
Advanced Pulmonary Research Institute Loxahatchee Groves Florida 33470 Recruiting
Reed Medical Research Miami Florida 33176 Recruiting
Renstar Medical Research Ocala Florida 34470 Recruiting
HCA Florida Ocala Imaging Center Ocala Florida 34471 Recruiting
Ocala Lung and Critical Care Associates Ocala Florida 34471 Recruiting
Renstar Medical Research Ocala Florida 34471 Recruiting
Coastal Medical Research Institute, LLC St. Petersburg Florida 33704 Recruiting
Coastal Pulmonary and Critical Care, P.L.C St. Petersburg Florida 33704 Recruiting
Clinical Research Trials of Florida, Inc. Tampa Florida 33607 Recruiting
Clinical Site Partners, LLC dba Flourish Research Winter Park Florida 32789 Recruiting
Cpcc-Research Llc East Point Georgia 30344 Recruiting
Centricity Research Rincon Pulmonology Rincon Georgia 31326 Recruiting
ASHA Clinical Research - Munster, LLC Hammond Indiana 46324 Recruiting
Methodist Hospital Southlake Merrillville Indiana 46410 Recruiting
University of Kansas Medical Center Kansas City Kansas 66160 Not yet recruiting
Southern Clinical Research, LLC Zachary Louisiana 70791 Recruiting
Paul A. Shapero, MD, PA Bangor Maine 04401 Not yet recruiting
Exordia Medical Research Inc. Fall River Massachusetts 02723 Not yet recruiting
Infinity Medical Research North Dartmouth Massachusetts 02747 Not yet recruiting
Revival Research Institute, LLC Dearborn Michigan 48126 Recruiting
AA Medical Research Center Flint Michigan 48504 Recruiting
Revive Research Institute, Inc. Southfield Michigan 48075 Recruiting
Oakland Medical Research Troy Michigan 48085 Recruiting
Washington University School of Medicine St Louis Missouri 63108 Recruiting
Barnes-Jewish Hospital Investigational Drug Service St Louis Missouri 63110 Recruiting
Barnes-Jewish Hospital St Louis Missouri 63110 Recruiting
Washington University School of Medicine St Louis Missouri 63110 Recruiting
Washington University School-Cardiovascular Imaging and Clinical Research Core Laboratory St Louis Missouri 63110 Recruiting
Henderson Clinical Trials Henderson Nevada 89052 Recruiting
Northwell Health Physician Partners at Chappaqua Chappaqua New York 10514 Not yet recruiting
New York Presbyterian Queens Flushing New York 11355 Not yet recruiting
Northern Westchester Hospital Mount Kisco New York 10549 Not yet recruiting
Salem Chest Specialists Winston-Salem North Carolina 27103 Recruiting
Southeastern Research Center Winston-Salem North Carolina 27103 Recruiting
Toledo Institute of Clinical Research Inc. Toledo Ohio 43617 Not yet recruiting
Clinical Research Associates of Central PA, LLC DuBois Pennsylvania 15801 Recruiting
Bogan Sleep Consultants, LLC Columbia South Carolina 29201 Recruiting
Velocity Clinical Research, Gaffney Gaffney South Carolina 29340 Recruiting
Clinical Research of Rock Hill Rock Hill South Carolina 29732 Recruiting
Velocity Clinical Research, Spartanburg Spartanburg South Carolina 29303 Recruiting
Health Concepts Rapid City South Dakota 57702 Recruiting
Clinical Trials Center of Middle Tennessee, LLC Franklin Tennessee 37067 Recruiting
Premier Research Center, LLC Hendersonville Tennessee 37075 Recruiting
South Texas Medical Research Institute, Inc., DBA TTS Research Boerne Texas 78006 Recruiting
Ten20 Clinical Research Carrollton Texas 75010 Recruiting
Horizon Clinical Research Group Cypress Texas 77429 Recruiting
Alina Clinical Trials, LLC. Dallas Texas 75209 Recruiting
Greater Heights & Memorial Pulmonary and Sleep Houston Texas 77008 Recruiting
Houston Pulmonary Sleep and Allergy Associates Houston Texas 77065 Recruiting
Sherman Clinical Research Sherman Texas 75090 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 59 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07363694, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 30, 2026 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07363694 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →